The Secretary of State was right to say that patients’ views have been neglected, and that they need to be central to this review. My constituents who have been impacted by Primodos lost faith in the working group’s review, not least because of that concern. How far will this review go? Will it, for instance, look into the fact that there might be a diminished amount of evidence available because the medical records of women who took Primodos were destroyed, including those of my constituents?
Medicines and Medical Devices Safety Review
Proceeding contribution from
Neil Gray
(Scottish National Party)
in the House of Commons on Wednesday, 21 February 2018.
It occurred during Ministerial statement on Medicines and Medical Devices Safety Review.
Type
Proceeding contribution
Reference
636 c182
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2020-07-09 15:43:23 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000046
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000046
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000046